News
New drug delivery technologies, such as nanoparticles, hydrogels, and self-powered microgrippers, are showing great potential ...
Joining me to discuss the best approach to diagnosis and treatment are two experts, Dr. Shannon Chang. She's the director of clinical operations at the Inflammatory Bowel Disease Center at NYU ...
7d
Investor's Business Daily on MSNWhy IBD Stock Of The Day Quest Diagnostics Sidestepped The Sell-OffQuest Diagnostics is Thursday's IBD Stock Of The Day. Shares are lingering in a buy zone, helped by a Texas court's ruling.
Biomerica has received CE-marking for its food intolerance tests tailored for ulcerative colitis (UC) and Crohn's disease, under the EU's In Vitro Diagnostic Medical Devices Regulation (IVDR).
The global fecal calprotectin test market is on a trajectory of substantial growth, with projections estimating an increase ...
This study validates criteria to identify patients with inflammatory bowel disease (IBD) at risk of worsening disease who may benefit from early treatment with advanced therapies.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results